Exelixis (EXEL) Q4 Earnings & Revenues Beat, Cabometyx Strong Posted byZacks Equity Research February 18, 2022 Leave a comment on Exelixis (EXEL) Q4 Earnings & Revenues Beat, Cabometyx Strong Exelixis (EXEL) beats on both earnings and revenues in the fourth quarter. Both figures increase on a year-over-year basis.